Prima BioMed Announces Granting of Patent Number US 9,244,059 Eentitled Cytotoxic Anti-LAG-3 Monoclonal Antibody and its Use in the Treatment or Prevention of Organ Transplant Rejection and Autoimmune Disease'
January 28, 2016 at 07:15 AM EST
Prima BioMed Ltd (NASDAQ: PBMD) announces the granting of patent number US 9,244,059 entitled "Cytotoxic anti-LAG-3 ...
